|
ÆÊÄ¿³ØÆà |
[Local CRO] HCO (ÀÌ»ç±Þ)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
12³â¡è |
03.31 |
02.14 |
|
|
ÆÊÄ¿³ØÆà |
[Áß°ßÁ¦¾à»ç] ÀÓ»óPM
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
03.31 |
02.02 |
|
|
ÆÊÄ¿³ØÆà |
[½Å¾à°³¹ß»ç] ÀÓ»óPM
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
03.31 |
02.01 |
|
|
ÆÊÄ¿³ØÆà |
[±¹³»CRO] CO Head (ÀÓ¿ø±Þ)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
13³â¡è |
03.31 |
02.01 |
|
|
JYpartners |
ÀÓ»ó´ã´çÀÚ(Ã¥ÀÓ~¼ö¼®)
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
13³â¡è |
ä¿ë½Ã |
01.22 |
|
|
ÇÁ·ÎÇÚÁîÄÚ¸®¾Æ |
À¯¸í¹ÙÀÌ¿ÀÁ¦¾à»ç ÀÓ»óÆÀÀå(°úÂ÷Àå±Þ)
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
10³â¡è |
ä¿ë½Ã |
11.07 |
|
|
HRKorea |
Biometrics ´ã´çÀÚ Ã¤¿ë - ÀÓ»ó°³¹ß Àü·« ±âȹ, CRO °ü¸® °¨
¼¿ï ÀüÁö¿ª | ´ëÇпø(¼®»ç) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
07.31 |
11.07 |
|
|
HRKorea |
CPM (Clinical Project Manager) ´ã´çÀÚ Ã¤¿ë - ÀÓ»ó °³¹ß
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
07.31 |
11.07 |
|
|
HRKorea |
PV(Pharmacovigilance) ´ã´çÀÚ Ã¤¿ë - ÀÓ»ó½ÃÇè SAE Handlin
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
07.31 |
11.07 |
|
|
¿¡ÀÌÄ¡¾ËÄÁ¼³Æà |
📌 cra, PM, crm, ÀÓ»óÆÀÀå/ÀÓ¿ø, SSUÆÀÀå ÀçÅñîÁö~
Àü±¹ ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
10.26 |
|
|
HRKorea |
ÀÓ»ó´ã´çÀÚ – ÀÎüÀ¯·¡¹° ¿¬±¸ °ü¸®, ÀÓ»ó½ÃÇè ÁÖ¿ä
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
03.31 |
10.25 |
|
|
HRKorea |
CO Team (Clinical Operation Team, ÀÓ»óÆÀ) ´ë¸®-°úÀå ä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
03.31 |
10.23 |
|
|
ÇÁ·ÎÇÚÁîÄÚ¸®¾Æ |
´ëÇüÁ¦¾à»ç CRÆÀÀå
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
10³â¡è |
ä¿ë½Ã |
10.10 |
|
|
ÇÁ·ÎÇÚÁîÄÚ¸®¾Æ |
¿Ü±¹°èCRO DMA(1³âÀÌ»ó)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
10.10 |
|
|
ÇÁ·ÎÇÚÁîÄÚ¸®¾Æ |
´ëÇüÁ¦¾à»ç PMS PM(ÆÄÆ®Àå-´ë¸®±ÞÀÌ»ó)1¸í/ÆÀ¿ø 2¸í(»ç¿ø~ÁÖ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
09.28 |
|